Elisabeth Martinelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elisabeth Martinelli has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Annelie-Martina Weinberg
Department of Orthopedics and Traumatology, Medical University of Graz, 8036 Graz, Austria
2 shared publications - Karin Pichler
Medical University of Graz
2 shared publications - Peter J. Uggowitzer
Department of Metallurgy, Chair of Non‐Ferrous Metallurgy Montanuniversität Leoben Franz‐Josef‐Strasse 18 8700 Leoben Austria
2 shared publications - Giuseppe Musumeci
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
1 shared publication - Hans-Peter Brezinschek
Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
1 shared publication - Jörg F. Löffler
Laboratory of Metal Physics and Technology Department of Materials ETH Zurich Zurich Switzerland
1 shared publication
Latest Publications
- 6 February 2014
- Published by Springer Nature in JOM
- Vol. 66 (4) , 573-579
Immunological Response to Biodegradable Magnesium Implants
- 6 February 2014
- Published by Springer Nature in JOM
- Vol. 66 (4) , 573-579
Immunological Response to Biodegradable Magnesium Implants
- 21 November 2013
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (4) , 881-889
Cellular reactions to biodegradable magnesium alloys on human growth plate chondrocytes and osteoblasts
In recent decades operative fracture treatment using elastic stable intramedullary nails (ESINs) has mainly taken precedence over conservative alternatives in children. The development of biodegradable materials that could be used for ESINs would be a further step towards treatment improvement. Due to its mechanical and elastic properties, magnesium seems to be an ideal material for biodegradable implant application. The aim of this study was therefore to investigate the cellular reaction to biodegradable magnesium implants in vitro. Primary human growth plate chondrocytes and MG63 osteoblasts were used for this study. Viability and metabolic activity in response to the eluate of a rapidly and a slower degrading magnesium alloy were investigated. Furthermore, changes in gene expression were assessed and live cell imaging was performed. A superior performance of the slower degrading WZ21 alloy’s eluate was detected regarding cell viability and metabolic activity, cell proliferation and morphology. However, the ZX50 alloy’s eluate induced a favourable up-regulation of osteogenic markers in MG63 osteoblasts. This study showed that magnesium alloys for use in biodegradable implant application are well tolerated in both osteoblasts and growth plate chondrocytes respectively.
- 21 November 2013
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (4) , 881-889
Cellular reactions to biodegradable magnesium alloys on human growth plate chondrocytes and osteoblasts
In recent decades operative fracture treatment using elastic stable intramedullary nails (ESINs) has mainly taken precedence over conservative alternatives in children. The development of biodegradable materials that could be used for ESINs would be a further step towards treatment improvement. Due to its mechanical and elastic properties, magnesium seems to be an ideal material for biodegradable implant application. The aim of this study was therefore to investigate the cellular reaction to biodegradable magnesium implants in vitro. Primary human growth plate chondrocytes and MG63 osteoblasts were used for this study. Viability and metabolic activity in response to the eluate of a rapidly and a slower degrading magnesium alloy were investigated. Furthermore, changes in gene expression were assessed and live cell imaging was performed. A superior performance of the slower degrading WZ21 alloy’s eluate was detected regarding cell viability and metabolic activity, cell proliferation and morphology. However, the ZX50 alloy’s eluate induced a favourable up-regulation of osteogenic markers in MG63 osteoblasts. This study showed that magnesium alloys for use in biodegradable implant application are well tolerated in both osteoblasts and growth plate chondrocytes respectively.